科学图书馆
-
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trialLopes RD, Vora AN, Liaw D et al. -
Homeostatic Chemokines and Prognosis in Patients With Acute Coronary SyndromesKC, M Hartford, A Ravn-Fischer, E Lorentzen et al.
-
Late Survival Benefit of Percutaneous Coronary Intervention Compared With Medical Therapy in Patients With Coronary Chronic Total Occlusion: A 10-Year Follow-Up StudyTK Park, SH Lee, S-H Choi et al.
-
Systems of Care for ST-Segment–Elevation Myocardial Infarction: A Policy Statement From the American Heart AssociationAK Jacobs, MJ Ali, , and on behalf of the American Heart Association Advocacy Coordinating Committee
-
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary SyndromesC Laudani, A Greco,G Occhipinti et al.
-
Canadian Multicenter Chronic Total Occlusion Registry: Ten-Year Follow-Up Results of Chronic Total Occlusion RevascularizationBH Strauss, ML Knudtson, AN Cheema et al.
-
Association of Thrombus Aspiration With Time and Mortality Among Patients With ST-Segment Elevation Myocardial Infarction: A Post Hoc Analysis of the Randomized TOTAL TrialR Moxham, V Džavík; J Cairns et al.
-
Predicting Major Adverse Events in Patients With Acute Myocardial InfarctionT Nestelberger, J Boeddinghaus, the APACE Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
